Not Signed In - Actavis Receives Approval For Ranitidine Syrup In The U.S.
Sat, 03 Mar 2007 08:00 AM EST
... Actavis U.S., the United States manufacturing and marketing division of the international generic pharmaceuticals company Actavis Group (ICEX: ACT), today announced that it has received approval from the U.S. Food & Drug Administration (FDA) to market Ranitidine Oral Solution USP. [click link for full article] ...
Related Topics
- Ranitidine
- Ranitidine Oral Syrup
- Guaifenesin and Hydrocodone Oral Syrup
- Carbinoxamine, Pseudoephedrine and Dextromethorphan Oral Syrup
- Theophylline Oral Solution, Syrup, or Suspension
- Zidovudine Oral Syrup
- Brompheniramine and Pseudoephedrine Oral Solution
- Pseudoephedrine, Guaifenesin, Dextromethhorphan Liquid
- Senna Oral Syrup
- Promethazine Oral Syrup
- Vaccine Testing & Approval
- Ranitidine Bismuth Citrate
- Chlorpheniramine, Pseudoephedrine and Hydrocodone Liquid
- Guaifenesin and Codeine Oral Solution or Syrup
- Hydroxyzine Oral Syrup
- Cetirizine Syrup
- Guaifenesin and Dextromethorphan Oral Solution
- Pyridostigmine Oral Syrup
- Carbinoxamine and Pseudoephedrine Oral Solution or Syrup
- Valproic Acid Oral Syrup
email this page
print this page
bookmark this page
feedback on this page
